Difference between revisions of "Pilgramm1"
(Imported from Wikispaces) |
|||
| Line 1: | Line 1: | ||
| − | |||
| − | <span style=" | + | <span style="line-height:normal">'''<span style="font-size:18.0pt"><span style="font-family:" times="" new="" roman",serif"="">Hyperbaric oxygen following acute acoustic trauma may be associated with improvement of tinnitus and more rapid return of hearing.</span></span>'''</span> |
| − | |||
| − | <span style="font-family: | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | + | <span style="line-height:normal">'''<span style="font-size:14.0pt"><span style="font-family:" times="" new="" roman",serif"="">Clinical Bottom Line:</span></span>'''</span> | |
| − | |||
| − | |||
| − | + | #<span style="line-height:normal"><span style="font-size:14.0pt"><span style="font-family:" times="" new="" roman",serif"="">Some evidence that hyperbaric oxygen improves tinnitus following acoustic trauma.</span></span></span> | |
| − | <span style="font-family: | + | #<span style="line-height:normal"><span style="font-size:14.0pt"><span style="font-family:" times="" new="" roman",serif"="">Some evidence that there may be some return of hearing</span></span></span> |
| − | <span style=" | + | #<span style="line-height:normal"><span style="font-size:14.0pt"><span style="font-family:" times="" new="" roman",serif"="">Hyperbaric oxygen may reduce the incidence of later deterioration in tinnitus or hearing</span></span></span> |
| − | <span style="font-family: | ||
| − | <span style="font-family: | ||
| − | + | ---- | |
| − | + | ||
| − | + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Citations:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">1. Pilgramm M, Schumann K. Hyperbaric oxygen therapy for acute acoustic trauma. Archives of Otolaryngology 1985; 241:247-254.</span></span></span> | |
| + | |||
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Clinical Scenario:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">A patient presenting with acoustic trauma resulting in hearing loss.</span></span></span> | ||
| + | |||
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Three-part Question:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">In patients with acute hearing loss and tinnitus following acoustic trauma, does the administration of hyperbaric oxygen, in addition to a standard sorbitol and dextran infusion, result in any improvement in outcome?</span></span></span> | ||
| + | |||
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Search Terms:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Acoustic trauma, deafness, tinnitus</span></span></span> | ||
| + | |||
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">The Study:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Non-blinded randomised controlled trial with intention-to-treat. Young male patients with acute acoustic trauma within the last 48 hours and associated with greater than 40dB hearing loss which has not improved more than 20dB in the first 24 hours.</span></span></span> | ||
| + | |||
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Control group (N = 59; 59 analysed):</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Standard IV protocol of 25g sorbitol and 50g dextran daily for 14 days. Half of this group also received 24mg betahistidine daily.</span></span></span> | ||
| + | |||
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Experimental group (N = 61; 61 analysed):</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Same two IV protocol groups plus 100% oxygen at 2.8 bar (?ATA) for 60 minutes daily for 10 days.</span></span></span> | ||
| + | |||
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">The Evidence:</span></span>'''</span> | ||
| + | |||
| + | {| class="Table" style="border:solid windowtext 1.0pt" | ||
|- | |- | ||
| − | | < | + | | style="border:solid windowtext 1.0pt" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Outcome</span></span>'''</span></p> |
| + | | style="width:50.1pt; border:solid windowtext 1.0pt" width="69" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Time to Outcome</span></span>'''</span></p> | ||
| + | | style="width:41.05pt; border:solid windowtext 1.0pt" width="57" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Air group</span></span>'''</span></p> | ||
| + | | style="width:48.15pt; border:solid windowtext 1.0pt" width="66" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">HBO group</span></span>'''</span></p> | ||
| + | | style="width:69.35pt; border:solid windowtext 1.0pt" width="94" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Relative risk reduction</span></span>'''</span></p> | ||
| + | | style="width:76.45pt; border:solid windowtext 1.0pt" width="104" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Absolute risk reduction</span></span>'''</span></p> | ||
| + | | style="width:51.9pt; border:solid windowtext 1.0pt" width="72" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">NNT</span></span>'''</span></p> | ||
|- | |- | ||
| − | | <span style'''" | + | | rowspan="2" style="border:solid windowtext 1.0pt" | |
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Deterioration after discharge</span></span>'''</span> | ||
| + | |||
| + | | style="width:50.1pt; border:solid windowtext 1.0pt" width="69" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">14 days</span></span></span></p> | ||
| + | | style="width:41.05pt; border:solid windowtext 1.0pt" width="57" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">0.27</span></span></span></p> | ||
| + | | style="width:48.15pt; border:solid windowtext 1.0pt" width="66" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">0.05</span></span></span></p> | ||
| + | | style="width:69.35pt; border:solid windowtext 1.0pt" width="94" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">82%</span></span></span></p> | ||
| + | | style="width:76.45pt; border:solid windowtext 1.0pt" width="104" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">0.22</span></span></span></p> | ||
| + | | style="width:51.9pt; border:solid windowtext 1.0pt" width="72" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">5</span></span></span></p> | ||
|- | |- | ||
| + | | style="width:50.1pt; border:solid windowtext 1.0pt; padding:.75pt .75pt .75pt .75pt" width="69" | | ||
| + | | style="width:41.05pt; border:solid windowtext 1.0pt; padding:.75pt .75pt .75pt .75pt" width="57" | | ||
| + | | style="width:48.15pt; border:solid windowtext 1.0pt" width="66" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">95% CI:</span></span></span></p> | ||
| + | | style="width:69.35pt; border:solid windowtext 1.0pt" width="94" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">36% to 100%</span></span></span></p> | ||
| + | | style="width:76.45pt; border:solid windowtext 1.0pt" width="104" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">0.1 to 0.35</span></span></span></p> | ||
| + | | style="width:51.9pt; border:solid windowtext 1.0pt" width="72" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">3 to 10</span></span></span></p> | ||
|} | |} | ||
| − | + | | |
| − | + | <div align="center"> | |
| + | {| class="Table" style="border:solid windowtext 1.0pt" | ||
|- | |- | ||
| − | | <span style | + | | style="width:109.0pt; border:solid windowtext 1.0pt" width="148" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Non-event outcomes</span></span>'''</span></p> |
| + | | style="width:56.75pt; border:solid windowtext 1.0pt" width="78" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Time to outcome</span></span>'''</span></p> | ||
| + | | style="width:57.15pt; border:solid windowtext 1.0pt" width="78" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">rTPA group</span></span>'''</span></p> | ||
| + | | style="width:71.3pt; border:solid windowtext 1.0pt" width="97" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">HBO and rTPA group</span></span>'''</span></p> | ||
| + | | style="width:68.75pt; border:solid windowtext 1.0pt" width="94" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Difference</span></span>'''</span></p> | ||
| + | | style="width:77.35pt; border:solid windowtext 1.0pt" width="106" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">P-value</span></span>'''</span></p> | ||
|- | |- | ||
| − | | <span style | + | | style="width:109.0pt; border:solid windowtext 1.0pt" width="148" | |
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Mean 6kHz hearing loss(dB)</span></span>'''</span> | ||
| + | |||
| + | | style="width:56.75pt; border:solid windowtext 1.0pt" width="78" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">42 days</span></span></span></p> | ||
| + | | style="width:57.15pt; border:solid windowtext 1.0pt" width="78" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">15</span></span></span></p> | ||
| + | | style="width:71.3pt; border:solid windowtext 1.0pt" width="97" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">2</span></span></span></p> | ||
| + | | style="width:68.75pt; border:solid windowtext 1.0pt" width="94" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">13</span></span></span></p> | ||
| + | | style="width:77.35pt; border:solid windowtext 1.0pt" width="106" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Not given</span></span></span></p> | ||
|- | |- | ||
| − | | <span style | + | | style="width:109.0pt; border:solid windowtext 1.0pt" width="148" | |
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Hearing improvement(%)</span></span>'''</span> | ||
| + | |||
| + | | style="width:56.75pt; border:solid windowtext 1.0pt" width="78" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">7 days</span></span></span></p> | ||
| + | | style="width:57.15pt; border:solid windowtext 1.0pt" width="78" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">52.7</span></span></span></p> | ||
| + | | style="width:71.3pt; border:solid windowtext 1.0pt" width="97" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">75.8</span></span></span></p> | ||
| + | | style="width:68.75pt; border:solid windowtext 1.0pt" width="94" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">23.1</span></span></span></p> | ||
| + | | style="width:77.35pt; border:solid windowtext 1.0pt" width="106" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Not given</span></span></span></p> | ||
|- | |- | ||
| − | | '''<span style | + | | style="width:109.0pt; border:solid windowtext 1.0pt" width="148" | |
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Hearing improvement(%)</span></span>'''</span> | ||
| + | |||
| + | | style="width:56.75pt; border:solid windowtext 1.0pt" width="78" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">42 days</span></span></span></p> | ||
| + | | style="width:57.15pt; border:solid windowtext 1.0pt" width="78" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">76.2</span></span></span></p> | ||
| + | | style="width:71.3pt; border:solid windowtext 1.0pt" width="97" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">87.7</span></span></span></p> | ||
| + | | style="width:68.75pt; border:solid windowtext 1.0pt" width="94" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">11.5</span></span></span></p> | ||
| + | | style="width:77.35pt; border:solid windowtext 1.0pt" width="106" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Not given</span></span></span></p> | ||
|- | |- | ||
| + | | style="width:109.0pt; border:solid windowtext 1.0pt" width="148" | | ||
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Mean improvement in tinnitus(dB)</span></span>'''</span> | ||
| + | |||
| + | | style="width:56.75pt; border:solid windowtext 1.0pt" width="78" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">42 days</span></span></span></p> | ||
| + | | style="width:57.15pt; border:solid windowtext 1.0pt" width="78" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">0</span></span></span></p> | ||
| + | | style="width:71.3pt; border:solid windowtext 1.0pt" width="97" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">6.5</span></span></span></p> | ||
| + | | style="width:68.75pt; border:solid windowtext 1.0pt" width="94" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">6.5</span></span></span></p> | ||
| + | | style="width:77.35pt; border:solid windowtext 1.0pt" width="106" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Not given</span></span></span></p> | ||
|} | |} | ||
| + | </div> | ||
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Comments:</span></span>'''</span> | ||
| + | |||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">1. Very difficult study to read as results are presented in a confusing manner.</span></span></span> | ||
| + | |||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">2. No significance testing for hearing improvement, tinnitus, rate of recovery or late deterioration make interpretation difficult. The non-event results above have been calculated by this reviewer</span></span></span> | ||
| + | |||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">3. No definition for 'deterioration' given.</span></span></span> | ||
| − | + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Appraised by:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Mike Bennett, Dept of Diving and Hyperbaric Medicine, Prince of Wales Hospital, Sydney; Sunday, 28 March 1999</span></span></span> | |
| − | <span style=" | ||
| − | <span style="font-family: | ||
| − | <span | ||
| − | + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Expiry date:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">June 2020</span></span></span> | |
| − | |||
| − | [[File: | + | [[File:Sumhorsa.gif|center|Sumhorsa.gif]] |
| − | <span style="display: block; text-align: center;"><span style="font-size: 230%;">[[Audiovestibular | + | <span style="display: block; text-align: center;"><span style="font-size: 230%;">[[Audiovestibular|BACK]]</span></span> |
Latest revision as of 21:00, 27 September 2021
Hyperbaric oxygen following acute acoustic trauma may be associated with improvement of tinnitus and more rapid return of hearing.
Clinical Bottom Line:
- Some evidence that hyperbaric oxygen improves tinnitus following acoustic trauma.
- Some evidence that there may be some return of hearing
- Hyperbaric oxygen may reduce the incidence of later deterioration in tinnitus or hearing
Citations:1. Pilgramm M, Schumann K. Hyperbaric oxygen therapy for acute acoustic trauma. Archives of Otolaryngology 1985; 241:247-254.
Clinical Scenario:A patient presenting with acoustic trauma resulting in hearing loss.
Three-part Question:In patients with acute hearing loss and tinnitus following acoustic trauma, does the administration of hyperbaric oxygen, in addition to a standard sorbitol and dextran infusion, result in any improvement in outcome?
Search Terms:Acoustic trauma, deafness, tinnitus
The Study:Non-blinded randomised controlled trial with intention-to-treat. Young male patients with acute acoustic trauma within the last 48 hours and associated with greater than 40dB hearing loss which has not improved more than 20dB in the first 24 hours.
Control group (N = 59; 59 analysed):Standard IV protocol of 25g sorbitol and 50g dextran daily for 14 days. Half of this group also received 24mg betahistidine daily.
Experimental group (N = 61; 61 analysed):Same two IV protocol groups plus 100% oxygen at 2.8 bar (?ATA) for 60 minutes daily for 10 days.
The Evidence:
Outcome |
Time to Outcome |
Air group |
HBO group |
Relative risk reduction |
Absolute risk reduction |
NNT |
|
Deterioration after discharge |
14 days |
0.27 |
0.05 |
82% |
0.22 |
5 |
95% CI: |
36% to 100% |
0.1 to 0.35 |
3 to 10 |
Non-event outcomes |
Time to outcome |
rTPA group |
HBO and rTPA group |
Difference |
P-value |
|
Mean 6kHz hearing loss(dB) |
42 days |
15 |
2 |
13 |
Not given |
|
Hearing improvement(%) |
7 days |
52.7 |
75.8 |
23.1 |
Not given |
|
Hearing improvement(%) |
42 days |
76.2 |
87.7 |
11.5 |
Not given |
|
Mean improvement in tinnitus(dB) |
42 days |
0 |
6.5 |
6.5 |
Not given |
Comments:
1. Very difficult study to read as results are presented in a confusing manner.
2. No significance testing for hearing improvement, tinnitus, rate of recovery or late deterioration make interpretation difficult. The non-event results above have been calculated by this reviewer
3. No definition for 'deterioration' given.
Appraised by:Mike Bennett, Dept of Diving and Hyperbaric Medicine, Prince of Wales Hospital, Sydney; Sunday, 28 March 1999
Expiry date:June 2020